Selected research
Market Structure
Global Azithromycin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Azithromycin Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Azithromycin Drug include Teva, Sandoz, Mylan, Pfizer, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation, Zydus Pharmaceuticals, Wockhardt and PLIVA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Azithromycin Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Azithromycin Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Azithromycin Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Azithromycin Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Azithromycin Drug Segment by Company
Teva
Sandoz
Mylan
Pfizer
Hainan Poly Pharm
Hainan Hailing Chemipharma Corporation
Zydus Pharmaceuticals
Wockhardt
PLIVA
Lupin
Gland Pharma Limited
CSPC Ouyi Pharmaceutical
CSPC
Aurobindo Pharma
Akorn
Azithromycin Drug Segment by Type
Oral
Injection
Azithromycin Drug Segment by Application
Hospital
Drug Store
Azithromycin Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azithromycin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Azithromycin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azithromycin Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Azithromycin Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Azithromycin Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Azithromycin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Azithromycin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Hospital
- Drug Store
Companies covered
- Teva
- Sandoz
- Mylan
- Pfizer
- Hainan Poly Pharm
- Hainan Hailing Chemipharma Corporation
- Zydus Pharmaceuticals
- Wockhardt
- PLIVA
- Lupin
- Gland Pharma Limited
- CSPC Ouyi Pharmaceutical
- CSPC
- Aurobindo Pharma
- Akorn
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Azithromycin Drug Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Azithromycin Drug Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Azithromycin Drug Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Azithromycin Drug Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Azithromycin Drug Market Dynamics
- 2.1 Azithromycin Drug Industry Trends
- 2.2 Azithromycin Drug Industry Drivers
- 2.3 Azithromycin Drug Industry Opportunities and Challenges
- 2.4 Azithromycin Drug Industry Restraints
3 Azithromycin Drug Market by Manufacturers
- 3.1 Global Azithromycin Drug Revenue by Manufacturers (2021-2026)
- 3.2 Global Azithromycin Drug Sales by Manufacturers (2021-2026)
- 3.3 Global Azithromycin Drug Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Azithromycin Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Azithromycin Drug Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Azithromycin Drug Manufacturers, Product Type & Application
- 3.7 Global Azithromycin Drug Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Azithromycin Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Azithromycin Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Azithromycin Drug Tier 1, Tier 2, and Tier 3
4 Azithromycin Drug Market by Type
- 4.1 Azithromycin Drug Type Introduction
- 4.1.1 Oral
- 4.1.2 Injection
- 4.2 Global Azithromycin Drug Sales by Type
- 4.2.1 Global Azithromycin Drug Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Azithromycin Drug Sales by Type (2021-2032)
- 4.2.3 Global Azithromycin Drug Sales Market Share by Type (2021-2032)
- 4.3 Global Azithromycin Drug Revenue by Type
- 4.3.1 Global Azithromycin Drug Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Azithromycin Drug Revenue by Type (2021-2032)
- 4.3.3 Global Azithromycin Drug Revenue Market Share by Type (2021-2032)
5 Azithromycin Drug Market by Application
- 5.1 Azithromycin Drug Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drug Store
- 5.2 Global Azithromycin Drug Sales by Application
- 5.2.1 Global Azithromycin Drug Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Azithromycin Drug Sales by Application (2021-2032)
- 5.2.3 Global Azithromycin Drug Sales Market Share by Application (2021-2032)
- 5.3 Global Azithromycin Drug Revenue by Application
- 5.3.1 Global Azithromycin Drug Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Azithromycin Drug Revenue by Application (2021-2032)
- 5.3.3 Global Azithromycin Drug Revenue Market Share by Application (2021-2032)
6 Global Azithromycin Drug Sales by Region
- 6.1 Global Azithromycin Drug Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Azithromycin Drug Sales by Region (2021-2032)
- 6.2.1 Global Azithromycin Drug Sales by Region (2021-2026)
- 6.2.2 Global Azithromycin Drug Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Azithromycin Drug Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Azithromycin Drug Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Azithromycin Drug Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Azithromycin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Azithromycin Drug Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Azithromycin Drug Revenue by Region
- 7.1 Global Azithromycin Drug Revenue by Region
- 7.1.1 Global Azithromycin Drug Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Azithromycin Drug Revenue by Region (2021-2026)
- 7.1.3 Global Azithromycin Drug Revenue by Region (2027-2032)
- 7.1.4 Global Azithromycin Drug Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Azithromycin Drug Revenue (2021-2032)
- 7.2.2 North America Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Azithromycin Drug Revenue (2021-2032)
- 7.3.2 Europe Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Azithromycin Drug Revenue (2021-2032)
- 7.4.2 Asia-Pacific Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Azithromycin Drug Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Azithromycin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Azithromycin Drug Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Sandoz
- 8.2.1 Sandoz Company Information
- 8.2.2 Sandoz Business Overview
- 8.2.3 Sandoz Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sandoz Azithromycin Drug Product Portfolio
- 8.2.5 Sandoz Recent Developments
- 8.3 Mylan
- 8.3.1 Mylan Company Information
- 8.3.2 Mylan Business Overview
- 8.3.3 Mylan Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mylan Azithromycin Drug Product Portfolio
- 8.3.5 Mylan Recent Developments
- 8.4 Pfizer
- 8.4.1 Pfizer Company Information
- 8.4.2 Pfizer Business Overview
- 8.4.3 Pfizer Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Pfizer Azithromycin Drug Product Portfolio
- 8.4.5 Pfizer Recent Developments
- 8.5 Hainan Poly Pharm
- 8.5.1 Hainan Poly Pharm Company Information
- 8.5.2 Hainan Poly Pharm Business Overview
- 8.5.3 Hainan Poly Pharm Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hainan Poly Pharm Azithromycin Drug Product Portfolio
- 8.5.5 Hainan Poly Pharm Recent Developments
- 8.6 Hainan Hailing Chemipharma Corporation
- 8.6.1 Hainan Hailing Chemipharma Corporation Company Information
- 8.6.2 Hainan Hailing Chemipharma Corporation Business Overview
- 8.6.3 Hainan Hailing Chemipharma Corporation Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hainan Hailing Chemipharma Corporation Azithromycin Drug Product Portfolio
- 8.6.5 Hainan Hailing Chemipharma Corporation Recent Developments
- 8.7 Zydus Pharmaceuticals
- 8.7.1 Zydus Pharmaceuticals Company Information
- 8.7.2 Zydus Pharmaceuticals Business Overview
- 8.7.3 Zydus Pharmaceuticals Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Zydus Pharmaceuticals Azithromycin Drug Product Portfolio
- 8.7.5 Zydus Pharmaceuticals Recent Developments
- 8.8 Wockhardt
- 8.8.1 Wockhardt Company Information
- 8.8.2 Wockhardt Business Overview
- 8.8.3 Wockhardt Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Wockhardt Azithromycin Drug Product Portfolio
- 8.8.5 Wockhardt Recent Developments
- 8.9 PLIVA
- 8.9.1 PLIVA Company Information
- 8.9.2 PLIVA Business Overview
- 8.9.3 PLIVA Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 PLIVA Azithromycin Drug Product Portfolio
- 8.9.5 PLIVA Recent Developments
- 8.10 Lupin
- 8.10.1 Lupin Company Information
- 8.10.2 Lupin Business Overview
- 8.10.3 Lupin Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Lupin Azithromycin Drug Product Portfolio
- 8.10.5 Lupin Recent Developments
- 8.11 Gland Pharma Limited
- 8.11.1 Gland Pharma Limited Company Information
- 8.11.2 Gland Pharma Limited Business Overview
- 8.11.3 Gland Pharma Limited Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Gland Pharma Limited Azithromycin Drug Product Portfolio
- 8.11.5 Gland Pharma Limited Recent Developments
- 8.12 CSPC Ouyi Pharmaceutical
- 8.12.1 CSPC Ouyi Pharmaceutical Company Information
- 8.12.2 CSPC Ouyi Pharmaceutical Business Overview
- 8.12.3 CSPC Ouyi Pharmaceutical Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 CSPC Ouyi Pharmaceutical Azithromycin Drug Product Portfolio
- 8.12.5 CSPC Ouyi Pharmaceutical Recent Developments
- 8.13 CSPC
- 8.13.1 CSPC Company Information
- 8.13.2 CSPC Business Overview
- 8.13.3 CSPC Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 CSPC Azithromycin Drug Product Portfolio
- 8.13.5 CSPC Recent Developments
- 8.14 Aurobindo Pharma
- 8.14.1 Aurobindo Pharma Company Information
- 8.14.2 Aurobindo Pharma Business Overview
- 8.14.3 Aurobindo Pharma Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Aurobindo Pharma Azithromycin Drug Product Portfolio
- 8.14.5 Aurobindo Pharma Recent Developments
- 8.15 Akorn
- 8.15.1 Akorn Company Information
- 8.15.2 Akorn Business Overview
- 8.15.3 Akorn Azithromycin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Akorn Azithromycin Drug Product Portfolio
- 8.15.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Azithromycin Drug Value Chain Analysis
- 9.1.1 Azithromycin Drug Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Azithromycin Drug Production Mode & Process
- 9.2 Azithromycin Drug Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Azithromycin Drug Distributors
- 9.2.3 Azithromycin Drug Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst